Is a
Acquisition attributes
Acquired Company
Acquirer
Acquisition Amount (USD)
200,000,000
Date Announced
July 19, 2018
Transaction Date Closed
August 23, 2018
PTC Therapeutics announced its plans to acquire Agilis Biotherapeutics on July 19, 2019. The deal closed on August 23, 2018, with an upfront payment of $50 million in cash and $150 million in stock holdings bringing the total purchase price to $200 million.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.